Denali Therapeutics Inc Sustainability Reports
Denali Therapeutics Inc. is a biopharmaceutical company focused on developing a broad portfolio of product candidates engineered to cross the blood-brain barrier for the treatment of neurodegenerative and lysosomal storage diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300ZTQ2HO18L3Q830
FIGI: BBG008P7F878
3 reports from 2018 to 2025
